Review articleVarices and Variceal Hemorrhage in Cirrhosis: A New View of an Old Problem
Section snippets
Clinical Settings
Therapy of varices and variceal hemorrhage now is stratified depending on the different clinical stages in the natural history of portal hypertension,12, 13 as follows: (1) the patient with compensated cirrhosis without clinically significant portal hypertension; (2) the patient with compensated cirrhosis with clinically significant portal hypertension who has not yet developed varices; (3) the patient with cirrhosis and clinically significant portal hypertension with gastroesophageal varices
Conclusions
Marked advances in the knowledge of portal hypertension over the past decades have resulted in the introduction of new effective treatments that have led to a significant improvement in the prognosis of portal hypertension. In parallel, major advances in the development of prognostic markers have allowed for risk stratification and redefinition of end points. We now recognize that management of patients at different prognostic stages is different, resulting in a more personalized approach to
References (55)
- et al.
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis
Gastroenterology
(2007) - et al.
Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis
J Hepatol
(2009) Expanding consensus in portal hypertension. Report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension
J Hepatol
(2015)- et al.
Natural history and prognostic indicators of survival in cirrhosis. A systematic review of 118 studies
J Hepatol
(2006) - et al.
Histological-hemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis
J Hepatol
(2006) - et al.
Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial
Gastroenterology
(2009) - et al.
Evolution in the understanding of the pathophysiological basis of portal hypertension: how changes in paradigm are leading to successful new treatments
J Hepatol
(2015) - et al.
Surgical resection of hepatocellular carcinoma in cirrhotic patients. Prognostic value of preoperative portal pressure
Gastroenterology
(1996) - et al.
Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding
Gastroenterology
(2009) - et al.
Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trial
J Hepatol
(2014)
A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis
Gastroenterology
Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial
Gastroenterology
Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection
Hepatology
Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage
Gastroenterology
Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study
J Hepatol
Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study
J Hepatol
Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleeding
J Hepatol
The hepatic venous pressure gradient: anything worth doing should be done right
Hepatology
Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis
N Engl J Med
Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis
Hepatology
Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis
Am J Gastroenterol
Management of varices and variceal hemorrhage in cirrhosis
N Engl J Med
Improved survival after variceal bleeding in patients with cirrhosis over the past two decades
Hepatology
Effectiveness of combined pharmacologic and ligation therapy in high-risk patients with acute esophageal variceal bleeding
Am J Gastroenterol
Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage
Hepatology
Natural history of cirrhosis
Now there are many (stages) where before there was one: in search of a pathophysiological classification of cirrhosis
Hepatology
Cited by (69)
Secondary Prevention of Esophageal Variceal Bleeding Is Often Imperfect: A National, Population-Based Cohort Study of 3592 Patients
2023, Clinical Gastroenterology and HepatologyThe impact of race and gender on the outcomes of patients with acetaminophen-induced acute liver failure: Propensity score-matched analysis of the NIS database
2023, European Journal of Gastroenterology and Hepatology
Conflicts of interest The authors disclose no conflicts.
Funding Supported by National Institutes of Health grants P-30DK 034989 (G.G.T.). The Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas is supported by the Instituto de Salud Carlos III (J.B.). Also supported in part by a grant from the Instituto de Salud Carlos III (PI13/00341) in a program co-funded by European Regional Development Fund (ERDF), European Union (J.B.).